Table 1 Clinical features of 49 individuals with RNU4-2 variants

From: De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome

Clinical feature

   

Individuals (n)

 

49

 

Sex

 

21 F, 28 M

 
  

Median

Range

Age at last evaluation (years)

 

10

2–38

Maternal age at birth (years)a

 

32

22–41

Paternal age at birth (years)b

 

33

26–45

  

Countc

Percentage (%)

Growth

IUGR

8 out of 45

18

Short stature

37 out of 49

76

Microcephaly

37 out of 48

77

 - congenital

19 out of 37

 

 - acquired

9 out of 37

 

 - not specified

9 out of 37

 

Neurodevelopmental

GDD

49 out of 49

100

 - severe

34 out of 49

 

 - moderate

10 out of 49

 

 - not specified

5 out of 49

 

Ambulatory (>5 years old)

30 out of 36

83

 - abnormal gait

7 out of 30

 

 - not specified

23 out of 30

 

Speech abnormality

45 out of 48

94

 - non-verbal

35 out of 45

 

 - few words

10 out of 45

 

ID

45 out of 45

100

Behavioural issues

30 out of 45

67

ASD

21 out of 44

48

Sleep issues

15 out of 32

47

Hypotonia

39 out of 45

87

Seizures

37 out of 48

77

Abnormal brain MRI

41 out of 45

91

Hearing

Hearing loss

10 out of 46d

22

Vision

Vision issues

38 out of 48

79

 - optic nerve hypoplasia

8 out of 37

22

 - strabismus

23 out of 45

51

 - nystagmus

18 out of 40

45

Gastrointestinal

Constipation

29 out of 44

66

GORD

21 out of 43

49

Feeding difficulties

32 out of 42

76

G-tube

13 out of 41

32

Growth problems

30 out of 43

70

Endocrine

 

17 out of 39

44

Bone and/or skeletal

 

27 out of 42

64

Limb

 

23 out of 42

55

Genitourinary

 

15 out of 43

35

Dental

 

17 out of 43

40

Cardiac

 

5 out of 43

12

Cutaneous

 

25 out of 44

57

Dysmorphic facial features

 

45 out of 48

94

  1. F, female; M, male; IUGR, intrauterine growth restriction; GDD, global developmental delay; ID, intellectual disability; ASD, autism spectrum disorder; MRI, magnetic resonance imaging; GORD, gastro-oesophageal reflux disease; G-tube, gastrostomy tube.
  2. aMaternal age available for 43 out of 49 individuals.
  3. bPaternal age available for 41 out of 49 individuals.
  4. cDenominator indicates the number of individuals for whom data were available.
  5. dOne individual has a dual diagnosis in GJB2 that would account for the hearing loss.